Harse David 4
Research Summary
AI-generated summary
TruBridge (TBRG) GM Harse David Receives 5,079-Share Award
What Happened Harse David, General Manager Patient Care at TruBridge (TBRG), received a grant of 5,079 restricted shares on April 8, 2026. The shares were issued at $0.00 (no cash consideration) as a compensatory award rather than an open-market purchase or sale.
Key Details
- Transaction type: Award/Grant (Code A) on 2026-04-08. Price per share reported: $0.00. Total upfront cash = $0.
- Vesting: The award vests in three equal annual installments (one-third each) beginning on the first anniversary of the grant date (see footnote).
- Section 16(b) status: This award is exempt from Section 16(b) short-swing profit rules pursuant to Rule 16b-3(d) (standard for compensatory grants).
- Shares owned after the transaction: Not specified in the provided filing.
- Filing timeliness: Form filed on 2026-04-09 for a 2026-04-08 transaction (filed the next day).
Context This is a restricted stock award typically issued as part of executive or employee compensation. Such grants reflect company compensation practices and vest over time; they are not direct open-market purchases that imply an immediate personal investment by the insider.